Combined Action of Anti-MUC1 Monoclonal Antibody and Pyrazole-Platinum(II) Complexes Reveals Higher Effectiveness towards Apoptotic Response in Comparison with Monotherapy in AGS Gastric Cancer Cells

MUC1 mucin is a transmembrane glycoprotein aberrantly overexpressed and underglycosylated in most epithelium origin cancers. Combining chemotherapeutics with monoclonal antibodies toward cancer-related antigens is one of the new strategies in cancer therapies. In this study, we assessed the effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Supruniuk, Katarzyna, Czarnomysy, Robert, Muszyńska, Anna, Radziejewska, Iwona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309157/
https://www.ncbi.nlm.nih.gov/pubmed/34206951
http://dx.doi.org/10.3390/pharmaceutics13070968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309157/
https://www.ncbi.nlm.nih.gov/pubmed/34206951
http://dx.doi.org/10.3390/pharmaceutics13070968

Ejemplares similares